These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 17221852)

  • 41. Cytoreductive surgery (cs) and hyperthermic intraperitoneal chemotherapy (hipec) in treatment of peritoneal surface malignances: report of a phase II clinical study.
    Asero S; Caruso M; Vallone N; Luciani AG; Lombardo V; Terranova G; Ettore G; Giannone G
    In Vivo; 2009; 23(4):645-7. PubMed ID: 19567402
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for the treatment of advanced primary and recurrent ovarian cancer.
    Sugarbaker PH
    Curr Opin Obstet Gynecol; 2009 Feb; 21(1):15-24. PubMed ID: 19124999
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment failure following complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from colorectal or appendiceal mucinous neoplasms.
    Bijelic L; Yan TD; Sugarbaker PH
    J Surg Oncol; 2008 Sep; 98(4):295-9. PubMed ID: 18726900
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Critical assessment of risk factors for complications after cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei.
    Saxena A; Yan TD; Chua TC; Morris DL
    Ann Surg Oncol; 2010 May; 17(5):1291-301. PubMed ID: 20039212
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cytoreductive surgery followed by intra peritoneal hyperthermic perfusion in the treatment of peritoneal surface malignancies: morbidity and mortality with closed abdomen technique.
    Kusamura S; Deraco M; Baratti D; Inglese MG; Costanzo P; Favaro M; Manzi R; Gavazzi C
    J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):207-12. PubMed ID: 16767933
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei from appendiceal mucinous neoplasms.
    Yan TD; Links M; Xu ZY; Kam PC; Glenn D; Morris DL
    Br J Surg; 2006 Oct; 93(10):1270-6. PubMed ID: 16838392
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Review of patients with peritoneal malignancy treated with peritonectomy and heated intraperitoneal chemotherapy.
    Hadi R; Saunders V; Utkina O; Clingan P; Kam P; Links M; Morris DL
    ANZ J Surg; 2006 Mar; 76(3):156-61. PubMed ID: 16626358
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Selection criteria for peritonectomy with hyperthermic intraoperative chemotherapy (HIPEC) in peritoneal carcinomatosis].
    Königsrainer I; Aschoff P; Zieker D; Beckert S; Glatzle J; Pfannenberg C; Miller S; Hartmann JT; Schroeder TH; Brücher BL; Königsrainer A
    Zentralbl Chir; 2008 Sep; 133(5):468-72. PubMed ID: 18924046
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phase II study of patients with peritoneal carcinomatosis from gastric cancer treated with preoperative systemic chemotherapy followed by peritonectomy and intraperitoneal chemotherapy.
    Hultman B; Lind P; Glimelius B; Sundbom M; Nygren P; Haglund U; Mahteme H
    Acta Oncol; 2013 May; 52(4):824-30. PubMed ID: 22974074
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adult respiratory distress syndrome occurring in two patients undergoing cytoreductive surgery plus perioperative intraperitoneal chemotherapy: case reports and a review of the literature.
    Alonso O; Sugarbaker PH
    Am Surg; 2000 Nov; 66(11):1032-6. PubMed ID: 11090013
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Factors influencing early postoperative recovery after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Arakelian E; Gunningberg L; Larsson J; Norlén K; Mahteme H
    Eur J Surg Oncol; 2011 Oct; 37(10):897-903. PubMed ID: 21783337
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reduced morbidity following cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion.
    Ahmad SA; Kim J; Sussman JJ; Soldano DA; Pennington LJ; James LE; Lowy AM
    Ann Surg Oncol; 2004 Apr; 11(4):387-92. PubMed ID: 15070598
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Complications and tolerance of heated intraperitoneal chemotherapy and cytoreductive surgery for peritoneal carcinomatosis: results of a phase I-II study of peritoneal carcinomatosis from different sources].
    Antoun S; Meshaka P; Soltani D; Blot F; Ducreux M; Lasser P; Nitenberg G; Elias D
    Bull Cancer; 2000 Sep; 87(9):665-70. PubMed ID: 11038416
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Strategies for the prevention and treatment of peritoneal carcinomatosis from gastrointestinal cancer.
    Sugarbaker PH
    Cancer Invest; 2005; 23(2):155-72. PubMed ID: 15813509
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phase II study of regional treatment for peritoneal carcinomatosis.
    Lanuke K; Mack LA; Temple WJ
    Am J Surg; 2009 May; 197(5):614-8; discussion 618. PubMed ID: 19393354
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Rationale for perioperative chemotherapy treatment in peritoneal carcinomatosis].
    Barrasa A; Van de Speeten K; Anthony Stuart O; Hendrick Sugarbaker P; Zappa L
    Cir Esp; 2009 Jan; 85(1):3-13. PubMed ID: 19239931
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Failure analysis of recurrent disease following complete cytoreduction and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer.
    Bijelic L; Yan TD; Sugarbaker PH
    Ann Surg Oncol; 2007 Aug; 14(8):2281-8. PubMed ID: 17503156
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery and perioperative intraperitoneal chemotherapy.
    Yan TD; Sim J; Morris DL
    Ann Surg Oncol; 2007 Jun; 14(6):1807-17. PubMed ID: 17342564
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis arising from gastric cancer].
    Cotte E; Gilly FN; Beaujard AC; Glehen O
    Cancer Radiother; 2008 Nov; 12(6-7):653-8. PubMed ID: 18639480
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Complete cytoreduction offers longterm survival in patients with peritoneal carcinomatosis from appendiceal tumors of unfavorable histology.
    Omohwo C; Nieroda CA; Studeman KD; Thieme H; Kostuik P; Ross AS; Holter DR; Gushchin V; Merriman B; Sardi A
    J Am Coll Surg; 2009 Sep; 209(3):308-12. PubMed ID: 19717034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.